Toggle light / dark theme

MRI warning as study says injection could cause deadly material to form in body

A chemical injected before MRI scans to help create sharper images may cause some patients to experience a potentially deadly complication in rare cases, a new study suggests.

Researchers from the University of New Mexico found that gadolinium – a toxic rare earth metal used in MRI scans – could mix with oxalic acid found in many foods to precipitate tiny nanoparticles of the metal in human tissues.

The research, published in the journal Magnetic Resonance Imaging, assessed the formation of these nanoparticles associated with potentially deadly health problems in the kidneys and other organs.

Combination of two cheap drugs could save lives after heart attack, study finds

Researchers at Imperial College London and Lund University in Sweden found that by giving heart attack patients two drugs together – statins and ezetimibe, a cholesterol-lowering drug – their risk of another heart attack, stroke or death was reduced.

“This study shows that we could save lives and reduce further heart attacks by giving patients a combination of two low-cost drugs,” said Prof Kausik Ray, of Imperial’s School of Public Health.

But at the moment patients across the world aren’t receiving these drugs together. That is causing unnecessary and avoidable heart attacks and deaths – and also places unnecessary costs on healthcare systems.

Researchers Identify New Blood Group After 50 Year Mystery

When a pregnant woman had her blood sampled back in 1972, doctors discovered it was mysteriously missing a surface molecule found on all other known red blood cells at the time.

After 50 years, this strange molecular absence finally led to researchers from the UK and Israel describing a new blood group system in humans. In 2024, the team published their paper on the discovery.

“It represents a huge achievement, and the culmination of a long team effort, to finally establish this new blood group system and be able to offer the best care to rare, but important, patients,” UK National Health Service hematologist Louise Tilley said last September, after nearly 20 years of personally researching this bloody quirk.

This Small Sensor Could Make Huge Impacts on Brain Injury Treatment

“Surgery means extensive recovery time and can significantly impact patient health. Our system doesn’t require surgery because we use a conventional stent, the catheter, as a delivery vehicle,” said W. Hong Yeo, the Harris Saunders Jr. Endowed Professor and an associate professor in the George W. Woodruff School of Mechanical Engineering.

Made from ultra-thin, flexible silicone, these nanosensors can be embedded in almost anything, from pacifiers to catheters. But size was just one element the researchers needed to consider when developing this device; accuracy was just as important.


Hong Yeo holds an in-stent nanomembrane sensor that can detect intracranial pressure.

A car accident, football game, or even a bad fall can lead to a serious or fatal head injury. Annually, traumatic brain injuries (TBI) cause half a million permanent disabilities and 50,000 deaths. Monitoring pressure inside the skull is key to treating TBI and preventing long-lasting complications.

Most of these monitoring devices are large and invasive, requiring surgical emplacement. But Georgia Tech researchers have recently created a sensor smaller than a dime. The miniature size offers huge benefits.

Moving forward from Cockcroft-Gault creatinine clearance to race-free estimated glomerular filtration rate to improve medication-related decision-making in adults across healthcare settings: A consensus of the National Kidney Foundation Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions

The NKF Workgroup for Implementation of Race-Free eGFR-Based Medication-Related Decisions suggests that health systems, health settings, clinical laboratories, electronic health record systems, compendia and data vendors, and healthcare practitioners involved with medication-related decision-making …

A fluid battery that can take any shape

Using electrodes in a fluid form, researchers at Linköping University have developed a battery that can take any shape. This soft and conformable battery can be integrated into future technology in a completely new way. Their study has been published in the journal Science Advances.

“The texture is a bit like toothpaste. The material can, for instance, be used in a 3D printer to shape the battery as you please. This opens up for a new type of technology,” says Aiman Rahmanudin, assistant professor at Linköping University.

It is estimated that more than a trillion gadgets will be connected to the Internet in 10 years’ time. In addition to traditional technology such as mobile phones, smartwatches and computers, this could involve wearable medical devices such as , pacemakers, hearing aids and various health monitoring sensors, and in the long term also , e-textiles and connected nerve implants.

Puberty triggers brain rewiring in genetic condition tied to autism, mouse study suggests

Changes in brain connectivity before and after puberty may explain why some children with a rare genetic disorder have a higher risk of developing autism or schizophrenia, according to a UCLA Health study.

Developmental psychiatric disorders like autism and schizophrenia are associated with changes in brain . However, the complexity of these conditions make it difficult to understand the underlying biological causes. By studying genetically defined , researchers at UCLA Health and collaborators have shed light on possible mechanisms.

The UCLA study examined a particular genetic condition called chromosome 22q11.2 deletion syndrome—caused by missing DNA on chromosome 22—which is associated with a higher risk of developing neuropsychiatric conditions such as autism and schizophrenia. But the underlying biological basis of this association has not been well understood.

Regulation of microbial gene expression: the key to understanding our gut microbiome

During the past two decades, gut microbiome studies have established the significant impact of the gut microbiota and its metabolites on host health. However, the molecular mechanisms governing the production of microbial metabolites in the gut environment remain insufficiently investigated and thus are poorly understood. Here, we propose that an enhanced understanding of gut microbial gene regulation, which is responsive to dietary components and gut environmental conditions, is needed in the research field and essential for our ability to effectively promote host health and prevent diseases through interventions targeting the gut microbiome.